CYH · Community Health Systems Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.96B | - | $3.09B | $3.13B | $3.16B | - | $3.09B | $3.14B | $3.14B | - |
| Cost of Revenue | $441.00M | - | $460.00M | $469.00M | $489.00M | - | $469.00M | $483.00M | $487.00M | - |
| Gross Profit | $2.52B | - | $2.63B | $2.66B | $2.67B | - | $2.62B | $2.66B | $2.65B | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | $2.68B | - | $2.84B | $2.62B | $2.88B | - | $3.29B | $2.90B | $2.91B | - |
| D&A | $114.00M | - | $108.00M | $105.00M | $105.00M | - | $117.00M | $125.00M | $115.00M | - |
| Operating Income | $281.00M | - | $243.00M | $512.00M | $284.00M | - | ($205.00M) | $238.00M | $231.00M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $89.00M | - | ($173.00M) | $118.00M | $42.00M | - | ($64.00M) | $24.00M | $28.00M | - |
| Net Income | ($58.00M) | - | $130.00M | $282.00M | ($13.00M) | - | ($391.00M) | ($13.00M) | ($41.00M) | - |
| EPS - Basic | ($0.43) | - | $0.97 | $2.11 | ($0.10) | - | ($2.95) | ($0.10) | ($0.32) | - |
| EPS - Diluted | ($0.43) | - | $0.96 | $2.09 | ($0.10) | - | ($2.95) | ($0.10) | ($0.32) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $712.00M | $260.00M | $123.00M | $456.00M | $431.00M | $37.00M | $33.00M | $39.00M | $48.00M | $38.00M |
| Accounts Receivable | $2.14B | $2.08B | $2.16B | $2.26B | $2.33B | $2.29B | $2.04B | $2.19B | $2.19B | $2.23B |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $790.00M | $842.00M | $894.00M | $970.00M | $974.00M | $913.00M | $842.00M | $896.00M | $941.00M | $912.00M |
| Current Assets | $3.77B | $3.23B | $3.20B | $3.66B | $3.41B | $3.30B | $3.11B | $3.20B | $3.17B | $3.21B |
| Total Assets | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B | $13.90B | $14.41B | $14.42B | $14.46B |
| Current Liabilities | $2.57B | $2.21B | $2.18B | $2.29B | $2.37B | $2.35B | $2.13B | $2.17B | $2.14B | $2.14B |
| Long-term Debt | $10.13B | $10.38B | $10.59B | $10.84B | $11.30B | $11.43B | $11.47B | $11.50B | $11.53B | $11.47B |
| Total Liabilities | $14.14B | $14.04B | $14.19B | $14.74B | $15.22B | $15.37B | $15.18B | $15.29B | $15.29B | $15.28B |
| Stockholders' Equity | ($1.45B) | ($1.39B) | ($1.50B) | ($1.63B) | ($1.92B) | ($1.91B) | ($1.82B) | ($1.44B) | ($1.43B) | ($1.39B) |
| Retained Earnings | ($3.63B) | ($3.57B) | ($3.68B) | ($3.81B) | ($4.09B) | ($4.08B) | ($4.01B) | ($3.62B) | ($3.60B) | ($3.56B) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($297.00M) | - | - | - | $120.00M | - | - | - | $96.00M | - |
| Investing Cash Flow | $1.02B | - | - | - | $444.00M | - | - | - | ($99.00M) | - |
| Financing Cash Flow | ($274.00M) | - | - | - | ($170.00M) | - | - | - | $13.00M | - |
| CapEx | $76.00M | - | - | - | $85.00M | - | - | - | $93.00M | - |
| Free Cash Flow | ($373.00M) | - | - | - | $35.00M | - | - | - | $3.00M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 85.1% | - | 85.1% | 85.0% | 84.5% | - | 84.8% | 84.6% | 84.5% | - |
| Operating margin | 9.5% | - | 7.9% | 16.3% | 9.0% | - | -6.6% | 7.6% | 7.4% | - |
| EBITDA margin | 13.3% | - | 11.4% | 19.7% | 12.3% | - | -2.8% | 11.6% | 11.0% | - |
| Net margin | -2.0% | - | 4.2% | 9.0% | -0.4% | - | -12.7% | -0.4% | -1.3% | - |
| Free cash flow margin | -12.6% | - | - | - | 1.1% | - | - | - | 0.1% | - |
| FCF / Net income | 6.43 | - | - | - | -2.69 | - | - | - | -0.07 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 287.1% | - | - | 29.5% | 144.8% | - | - | 218.2% | - | - |
| Return on assets | -0.4% | - | 1.0% | 2.1% | -0.1% | - | -2.8% | -0.1% | -0.3% | - |
| Return on equity | 4.0% | - | -8.7% | -17.3% | 0.7% | - | 21.4% | 0.9% | 2.9% | - |
| Return on invested capital | 1.6% | - | 2.1% | 3.9% | 1.5% | - | -1.7% | 1.2% | 1.8% | - |
| Liquidity | ||||||||||
| Current ratio | 1.47 | 1.46 | 1.47 | 1.59 | 1.44 | 1.41 | 1.46 | 1.47 | 1.49 | 1.50 |
| Quick ratio | 1.47 | 1.46 | 1.47 | 1.59 | 1.44 | 1.41 | 1.46 | 1.47 | 1.49 | 1.50 |
| Cash ratio | 0.28 | 0.12 | 0.06 | 0.20 | 0.18 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Leverage | ||||||||||
| Debt / Equity | -6.96 | -7.45 | -7.05 | -6.65 | -5.88 | -5.97 | -6.29 | -7.98 | -8.08 | -8.24 |
| Debt / Assets | 0.77 | 0.79 | 0.80 | 0.79 | 0.81 | 0.81 | 0.82 | 0.80 | 0.80 | 0.79 |
| Debt / EBITDA | 25.64 | - | 30.17 | 17.57 | 29.06 | - | - | 31.69 | 33.33 | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | -9.06 | -9.47 | -8.81 | -8.36 | -7.22 | -7.34 | -7.63 | -10.00 | -10.10 | -10.38 |
| Liabilities / Assets | 1.07 | 1.06 | 1.07 | 1.08 | 1.10 | 1.09 | 1.09 | 1.06 | 1.06 | 1.06 |
| Efficiency | ||||||||||
| Asset turnover | 0.22 | - | 0.23 | 0.23 | 0.23 | - | 0.22 | 0.22 | 0.22 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 263d | - | 255d | 263d | 269d | - | 241d | 255d | 255d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | 654d | - | 709d | 755d | 727d | - | 655d | 677d | 705d | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | 3.3x | 1.6x | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | 0.1x | - | 0.1x | 0.1x | 0.1x | - | 0.3x | 0.1x | 0.1x | - |
| EV / EBITDA | 24.8x | - | 31.1x | 17.6x | 28.9x | - | - | 32.8x | 34.5x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -6.1% | - | -0.1% | -0.2% | 0.6% | - | 0.1% | 0.8% | 1.0% | - |
| Revenue CAGR (3y) | -1.6% | - | 0.7% | 2.2% | 0.5% | - | -0.3% | 1.5% | 1.4% | - |
| Revenue CAGR (5y) | -0.3% | - | -0.3% | 4.5% | 0.9% | - | -1.0% | -1.0% | -1.4% | - |
| Gross profit growth (YoY) | -5.5% | - | 0.2% | 0.3% | 0.6% | - | 0.9% | 1.8% | 2.0% | - |
| Operating income growth (YoY) | -1.1% | - | - | 115.1% | 22.9% | - | - | -3.3% | 10.0% | - |
| Net income growth (YoY) | -346.2% | - | - | - | 68.3% | - | -329.7% | 65.8% | 19.6% | - |
| EPS growth (YoY) | -330.0% | - | - | - | 68.8% | - | -327.5% | 65.5% | 20.0% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | -0.2% | 27.9% | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | 1066.7% | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | -24.2% | - |
| Book value growth (YoY) | 24.4% | 27.2% | 17.6% | -13.2% | -34.7% | -37.5% | -24.6% | 3.2% | 1.2% | -1.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$12.48B totalManaged Care And Other Third Party Payors$5.97B · 47.9%
Medicare Managed Care$2.25B · 18.0%
Medicare$2.17B · 17.4%
Medicaid$1.99B · 15.9%
Self Pay Revenue$96.00M · 0.8%
Peer comparison
Same SIC group: Services-General Medical & Surgical Hospitals, NEC
Comparing COMMUNITY HEALTH SYSTEMS INC against the 5 most active filers in the same SIC group.
Dividends
$0.00/share trailing 12 months
| Ex-date | Per share |
|---|---|
| Dec 13, 2012 | $0.2066 |